Match Document Document Title
US20140227357 FILL FORMULATIONS AND CAPSULES AND METHOD OF USE TO AVOID MIGRATION OF FILL INTO OR THROUGH THE SHELL  
The present disclosure relates to fill formulations comprising at least one polymer and at least one fill component wherein the at least one fill component in the absence of the at least one...
US20060246128 Micronized tanaproget and compositions containing same  
The present invention provides compositions, desirably pharmaceutical compositions, containing micronized tanaproget. The compositions can also contain microcrystalline cellulose, croscarmellose...
US20120269888 BARRIER COMPOSITION  
The invention is directed to a barrier composition, to a vehicle comprising said barrier composition, to a layer comprising said barrier composition, to a foodstuff comprising said vehicle or...
US20140255476 COMPOSITIONS, DEVICES, AND METHODS FOR TREATING INFECTIONS  
Compositions, devices, and methods for treating infections.
US20140141074 CONCENTRATED THERAPEUTIC PHOSPHOLIPID COMPOSITIONS  
The invention relates to concentrated therapeutic phospholipid compositions; methods for treating or preventing diseases associated with cardiovascular disease, metabolic syndrome, inflammation...
US20130045275 SUSTAINED-RELEASE CHITOSAN CAPSULES COMPRISING CHITOSAN AND PHYTIC ACID  
The present invention relates to a chitosan capsule in which a soluble active ingredient is encapsulated in a matrix containing chitosan and phytic acid; a cross-linking method and materials...
US20110129528 SUSTAINED-RELEASE CHITOSAN CAPSULES COMPRISING CHITOSAN AND PHYTIC ACID  
The present invention relates to a chitosan capsule in which a soluble active ingredient is encapsulated in a matrix containing chitosan and phytic acid; a cross-linking method and materials...
US20130177644 METHODS FOR TREATING MULTIPLE MYELOMA WITH 4-(AMINO)-2-(2,6-DIOXO(3-PIPERIDYL))-ISOINDOLINE-1,3-DIONE  
Methods of treating, preventing and/or managing cancer as well as and diseases and disorders associated with, or characterized by, undesired angiogenesis are disclosed. Specific methods encompass...
US20130177642 METHODS FOR TREATING MULTIPLE MYELOMA WITH 4-(AMINO)-2-(2,6-DIOXO(3-PIPERIDYL))-ISOINDOLINE-1,3-DIONE  
Methods of treating, preventing and/or managing cancer as well as and diseases and disorders associated with, or characterized by, undesired angiogenesis are disclosed. Specific methods encompass...
US20060286162 Bicalutamide-adsorbates, process for preparing same, and pharmaceutical compositions thereof  
The present invention relates to an adsorbate, comprising an adsorbent and bicalutamide adsorbed on said adsorbent, a process for preparing same, and a pharmaceutical composition thereof.
US20130022672 Stabilized Amorphous Forms of Imatinib Mesylate  
The invention relates to the stabilized amorphous form of the methanesulfonic acid addition salt of 4-(4-methylpiperazin-1-ylmethyl)-N-[4-methyl-3-(4-(pyridin-3 -yl)-pyrimidin-2-ylamino)-phenyl]-be...
US20150037400 CYTOTOXIC AGENTS  
A method of killing a cell that is lacking in effective p53 protein activity, particularly as compared to wild type, is provided characterised in that it comprises delivering to the cell a single...
US20140079639 METHODS AND COMPOSITIONS FOR IDENTIFYING, PRODUCING AND USING PLANT-DERIVED PRODUCTS FOR MODULATING CELL FUNCTION AND AGING  
Provided herein are methods of culturing cells in vitro in order to exploit the biochemical production ability of the cells to make metabolites that are evaluated and harvested for their...
US20140161878 MULTI-NUTRIENT SUPPLEMENT AND USES THEREOF  
Various embodiments of the invention relate to compositions comprising vitamins, minerals and trace elements, antioxidants, amino acids, probiotics, and other components and methods for using such...
US20060246127 Moulded body made from a gelatine-free material filled with a liquid filling  
The invention relates to a moulded body, comprising a shell mass made from gelatine-free material and a liquid as filler, whereby the shell mass comprises at least one first biopolymer and at...
US20070098784 Delivery system for biological component  
A controlled release delivery system composition and method applied to humans and animals, for oral, anal or vaginal administration of a biological component is disclosed. Preferably, a bacterium...
US20140302135 Microencapsulation as a strategy for implementation and environmental safe-guarding of a paratransgenic approach to control of vector-borne diseases  
A microparticle comprising a pesticidal agent encapsulated within a polymer coating, the polymer coating comprising an oil-soluble dye wherein the oil-soluble dye and the polymer coating increases...
US20090130196 Bacteriophage composition  
Bacteriophage compositions, and methods for preparing bacteriophage compositions are provided. The method for producing an antibacterial composition involves adsorbing an aqueous solution of one...
US20050255156 Reverse-micellar delivery system for controlled transportation and enhanced absorption of agents  
The invention can be summarized as follows. The present invention provides a reverse-micellar delivery system for enhanced absorption of an agent of interest across biological membranes such as...
US20080311186 Composition Having Effect on Treatment and Prevention of Dry Eye Syndrome  
Provided is a composition comprising, as an active ingredient, at least one material selected from the group consisting of uridine and derivatives thereof which promote synthesis of hyaluronic...
US20070082045 Seamless capsule manufacturing method, seamless capsule manufacturing device and seamless capsule  
A seamless capsule manufacturing device comprises a multiple nozzle 7 for ejecting liquid drops into hardening liquid 10 and a flow passage tube 11 for containing hardening liquid 10. The flow...
US20080286354 COMPOSITION AND THERAPIES FOR HYPERLIPIDAEMIA-ASSOCIATED DISORDERS  
The invention relates to pharmaceutical compositions comprising at least one fibrate and at least one bile acid, and to methods for the treatment of hyperlipidaemia or elevated liver function...
US20070212407 Oral Composition A First Composition (A) And A Second Composition (B) As A Combination Product For Separate Or Consecutive Administration In The Cosmetic Treatment Of The Human Body  
The present invention relates to a composition suitable for oral delivery and including a first composition (a) containing a green tea extract and vitamin C, and optionally at least one metal...
US20110223243 ARTIFICIAL OXYGEN CARRIERS AND USE THEREOF  
The invention relates to dispersions of artificial oxygen carriers, wherein the dispersions contain capsules with reversible oxygen storage capacity, the capsules comprising an oxygen-permeable...
US20120213846 Stable Solid Formulation of a GC-C Receptor Agonist Polypeptide Suitable for Oral Administration  
Solid, stable formulations of linaclotide suitable for oral administration are described herein as are methods for preparing such formulations. The formulations described herein contain a...
US20110091541 Preparation of formulations of angiotensin II at1 receptors antagonists for the treatment of arterial hypertension, other cardiovascular illnesses and its complications  
Preparation of AT1 receptors antagonists formulations using the cyclodextrins, their derivatives and/or biodegradable polymers for the treatment of arterial hypertension, other cardiovascular...
US20100292669 METHOD AND APPARATUS FOR IN SITU DRUG DELIVERY DURING DISTRACTION OSTEOGENESIS  
A device and technique for the performance of distraction osteogenesis of bone with controlled drug delivery using a bead chain consisting of two bands and a series of drug delivery capsules...
US20070148227 PHYSICALLY/MOLECULARLY DISTRIBUTED AND/OR CHEMICALLY BOUND MEDICAMENTS IN CAPSULE SHELLS  
The present invention proposes a design to incorporate medicaments in the capsule shells (body and cap). Medicaments in the cap and body of the capsules may be different. Other medicaments in the...
US20140356420 MICRO-PARTICLE COMPRISING A PROTEIN EXTRACT FROM SWEET POTATO FOR EXTENDING SATIETY AND CONTROLLING BLOOD GLUCOSE AND LIPID LEVELS  
The present invention relates to a micro-particle for extending satiety and controlling blood glucose and lipid levels, comprising a core having the protein extract from sweet potato, an active...
US20120021050 NANOPARTICLE FORMULATED GLYCOLIPID ANTIGENS FOR IMMUNOTHERAPY  
A composition for stimulating NKT cells to produce anti-cancer and anti-viral cytokines without causing anergy of NKT cells includes a glycolipid antigen and a nanoparticle conjugated with the...
US20120237578 Microcapsules produced from blended sol-gel precursors and method for producing the same  
The present invention features microcapsule particles with an oil or aqueous liquid core, and shell composed of a blend of metal or semi-metal oxide polymers. Methods for preparing and using the...
US20060275358 Self-microemulsifying dosage forms of low solubility active ingredients such as co-enzyme Q10  
The invention includes dosage formulations, dosage forms and related methods for providing oral dosage forms of low solubility active ingredients such as coenzyme Q1O. The present invention...
US20070014846 PHARMACEUTICAL COMPOSITIONS COMPRISING FENOFIBRATE AND ATORVASTATIN  
Pharmaceutical compositions in particulate form or in solid dosage forms comprising a combination of fenofibrate and the HMG CoA reductase inhibitor atorvastatin or a pharmaceutically active salt...
US20130266644 SENSOR  
The present invention relates to a scaffolded sensor with a container comprising a drug for triggering drug release, wherein the scaffold is intrinsically conformationally metastable and a method...
US20130101663 Soluble tumor necrosis factor receptor (sTNF-R) used as a targeting agent to treat arthritis and other diseases  
This invention describes the use of sTNF-R as a targeting agent attached to liposomes incorporating anti-inflammatory drugs to treat arthritis and other inflammatory diseases. A variety of...
US20050163714 Capsules of multilayered neutral polymer films associated by hydrogen bonding  
Micro-, and nano-scale capsules comprising neutral (uncharged) polymeric layers, layers associated by hydrogen bonding and methods for making such capsules. The capsules of the invention are...
US20060292214 Nanoparticulate acetaminophen formulations  
The invention is directed to compositions comprising a nanoparticulate acetaminophen composition, or a salt or derivative thereof, having improved bioavailability. The nanoparticulate...
US20140227346 IMMUNOGENIC COMBINATION COMPOSITIONS AND USES THEREOF  
This invention generally relates to immunogenic compositions that comprise an RNA component and a polypeptide component. Immunogenic compositions that deliver antigens in two different forms—a...
US20150024041 Health Supplement using Guarana Extract  
The current invention is a supplement made from a combination of herbs, vitamins, amino acids which in the preferred embodiment is a 100% vegetarian liquid capsules that are ingested allow for...
US20080268034 Solid Oral Dosage Forms of Ziprasidone Containing Colloidal Silicone Dioxide  
The present invention relates to solid oral dosage forms of ziprasidone and salts thereof and processes for their preparation, containing colloidal silicon dioxide.
US20110311618 INHALABLE PARTICLES COMPRISING TIOTROPIUM  
The present invention relates to inhalable particles comprising a stabilized amorphous form of tiotropium with a stabilizing agent. It also relates to inhalable particles comprising a stabilized...
US20100178332 CELLULOSE-BASED FINE CORE PARTICLE AND PROCESS FOR PRODUCING THE SAME  
It is an object of the present invention to provide a fine core particle, which comprises a coating layer having a uniform thickness, and which can be used to produce, at a high yield, a small...
US20070065511 Controlled delivery creatine formulations and method of using the same  
Controlled delivery formulations of creatine and a method of using the same are disclosed. Creatine is combined with an encapsulation/delivery agent and/or excipient, which act in such a way as to...
US20110177010 Vitamin preparation  
Two-phase preparation for temporally gradual administration comprising a) a phase (A) comprising water soluble vitamins and/or the corresponding provitamins, wherein phase (A) does not contain...
US20060159744 Timed dual release dosage forms comprising a short acting hypnotic or a salt thereof  
The present invention relates to timed dual release dosage forms of short acting hypnotics or salts thereof adapted to release the short acting hypnotic over a predetermined time period, according...
US20060275360 Oral dosage forms comprising progesterone and methods of making and using the same  
The present invention relates to an oral pharmaceutical dosage form comprising micronized progesterone, an edible oil, a disintegrant, and a hydrophilic excipient. Particularly, the invention...
US20140308345 KRILL OIL AND REACTED ASTAXANTHIN COMPOSITION AND ASSOCIATED METHOD  
A method of enhancing cardiovascular health includes administering a therapeutic amount of a composition comprising krill oil reacted with astaxanthin. A medicine delivery system for the method...
US20090148515 TWO-PIECE METAL CAPSULE FOR ACCOMMODATING PHARMACEUTICAL PREPARATIONS FOR POWDER INHALERS  
The invention relates to novel two-piece metal capsules for accommodating pharmaceutical preparations to be used in powder inhalers as well as a method for producing said capsule. The inventive...
US20090035365 Density Controlled Capsule Particles and Methods of Making the Same  
The present invention discloses density controlled capsule particle and methods for making the same for use in a wide range of consumer and personal care products.
US20150190458 STABILIZED PHARMACEUTICAL FORMULATIONS OF A POTENT HCV INHIBITOR  
Described are various methods for stabilizing pharmaceutical formulations of a specific Hepatitis C Viral (HCV) inhibitor against the formation of a particular genotoxic degradation product. Such...